Parallel Advisors, LLC

SEC CIK: 0001690010
Latest filing: Aug 5, 2026

SEC filings (opens in a new tab)

KROS holding history

Keros Therapeutics, Inc. in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KROS overview All 13F holders of KROS Full Q2 2026 holdings

Shares (Q4 2022): 0; Sold out in Q4 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2022

Holdings of KROS by Parallel Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2022	0	$0	0.0%	−4−100.0%	Sold out	Holders
Q3 2022	4	$0	0.0%	+4	New	Holders
Q2 2022	0	$0	0.0%	−44−100.0%	Sold out	Holders
Q1 2022	44	$2.00K	<0.1%	+44	New	Holders